Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Gemcitabine Prodrugs

NuCana PLC 2015. Gemcitabine Prodrugs. WO 2015/198058; GB51857. [Patent].

Full text not available from this repository.

Abstract

This invention relates to a prodrug of the monophosphate nucleotide of the well-known oncology drug gemcitabine. Specifically, it relates to gemcitabine-[phenyl-benzoxy-L-alaninyl)]-phosphate when present as a single phosphate diastereoisomer and, in particular, it relates to the (S)-phosphate diastereoisomer which offers a remarkable and unexpected increase in solubility relative to the (R)-diastereoisomer. The (S)-phosphate epimer is also preferentially taken up into cyclodextrin solutions over the (R)-diastereoisomer.

Item Type: Patent
Date Type: Completion
Status: Published
Schools: Pharmacy
Related URLs:
Last Modified: 27 Sep 2021 10:56
URI: http://orca.cardiff.ac.uk/id/eprint/144402

Actions (repository staff only)

Edit Item Edit Item